Rationale: We reported a randomized trial demonstrating daily supplemental vitamin C to pregnant smokers significantly improved newborn pulmonary function tests. The current study tests these results in a new cohort using infant pulmonary function tests. Objectives: To determine if infants of pregnant smokers randomized to daily supplemental vitamin C would have improved forced expiratory flows (FEFs) at 3 months of age compared with those randomized to placebo, and to investigate the association of the α5 nicotinic acetylcholine receptor. Methods: A randomized, double-blind, placebo-controlled trial was conducted at three centers. Two hundred fifty-one pregnant smokers were randomized at 13-23 weeks of gestation: 125 randomized to vitamin C (500 mg/d) and 126 to placebo. Measurements and Main Results: The primary outcome was FEF75 at 3 months of age performed with the raised volume rapid thoracic compression technique (Jaeger/Viasys). FEF50 and FEF25-75 obtained from the same expiratory curves were prespecified secondary outcomes. The infants of pregnant smokers randomized to vitamin C (n = 113) had the following FEFs at 3 months of age compared with those randomized to placebo (n = 109) as measured by FEF75 (200.7 vs. 188.7 ml/s; adjusted 95% confidence interval [CI] for difference, -3.33 to 35.64; P = 0.10), FEF50 (436.7 vs. 408.5 ml/s; adjusted 95% CI for difference, 6.10-61.30; P = 0.02), and FEF25-75 (387.4 vs. 365.8 ml/s; adjusted 95% CI for difference, 0.92-55.34; P = 0.04). Infant FEFs seemed to be negatively associated with the maternal risk alleles for the α5 nicotinic acetylcholine receptor (rs16969968). Conclusions: Although the primary outcome of FEF75 was not improved after vitamin C supplementation to pregnant smokers, the predetermined secondary outcomes FEF50 and FEF25-75 were significantly improved. These results extend our previous findings and demonstrate improved airway function (FEF50 and FEF25-75) at 3 months of age in infants after vitamin C supplementation to pregnant smokers. Clinical trial registered with www.clinicaltrials.gov (NCT01723696).
RCT Entities:
Rationale: We reported a randomized trial demonstrating daily supplemental vitamin C to pregnant smokers significantly improved newborn pulmonary function tests. The current study tests these results in a new cohort using infant pulmonary function tests. Objectives: To determine if infants of pregnant smokers randomized to daily supplemental vitamin C would have improved forced expiratory flows (FEFs) at 3 months of age compared with those randomized to placebo, and to investigate the association of the α5 nicotinic acetylcholine receptor. Methods: A randomized, double-blind, placebo-controlled trial was conducted at three centers. Two hundred fifty-one pregnant smokers were randomized at 13-23 weeks of gestation: 125 randomized to vitamin C (500 mg/d) and 126 to placebo. Measurements and Main Results: The primary outcome was FEF75 at 3 months of age performed with the raised volume rapid thoracic compression technique (Jaeger/Viasys). FEF50 and FEF25-75 obtained from the same expiratory curves were prespecified secondary outcomes. The infants of pregnant smokers randomized to vitamin C (n = 113) had the following FEFs at 3 months of age compared with those randomized to placebo (n = 109) as measured by FEF75 (200.7 vs. 188.7 ml/s; adjusted 95% confidence interval [CI] for difference, -3.33 to 35.64; P = 0.10), FEF50 (436.7 vs. 408.5 ml/s; adjusted 95% CI for difference, 6.10-61.30; P = 0.02), and FEF25-75 (387.4 vs. 365.8 ml/s; adjusted 95% CI for difference, 0.92-55.34; P = 0.04). Infant FEFs seemed to be negatively associated with the maternal risk alleles for the α5 nicotinic acetylcholine receptor (rs16969968). Conclusions: Although the primary outcome of FEF75 was not improved after vitamin C supplementation to pregnant smokers, the predetermined secondary outcomes FEF50 and FEF25-75 were significantly improved. These results extend our previous findings and demonstrate improved airway function (FEF50 and FEF25-75) at 3 months of age in infants after vitamin C supplementation to pregnant smokers. Clinical trial registered with www.clinicaltrials.gov (NCT01723696).
Authors: Tracy A Manuck; Philip T Levy; Cynthia Gyamfi-Bannerman; Alan H Jobe; Carol J Blaisdell Journal: JAMA Pediatr Date: 2016-05-02 Impact factor: 16.193
Authors: Cindy T McEvoy; Diane Schilling; Nakia Clay; Keith Jackson; Mitzi D Go; Patricia Spitale; Carol Bunten; Maria Leiva; David Gonzales; Julie Hollister-Smith; Manuel Durand; Balz Frei; A Sonia Buist; Dawn Peters; Cynthia D Morris; Eliot R Spindel Journal: JAMA Date: 2014-05 Impact factor: 56.272
Authors: Augusto A Litonjua; Vincent J Carey; Nancy Laranjo; Benjamin J Harshfield; Thomas F McElrath; George T O'Connor; Megan Sandel; Ronald E Iverson; Aviva Lee-Paritz; Robert C Strunk; Leonard B Bacharier; George A Macones; Robert S Zeiger; Michael Schatz; Bruce W Hollis; Eve Hornsby; Catherine Hawrylowicz; Ann Chen Wu; Scott T Weiss Journal: JAMA Date: 2016-01-26 Impact factor: 56.272
Authors: Alison G Lee; Whitney Cowell; Srimathi Kannan; Harish B Ganguri; Farida Nentin; Ander Wilson; Brent A Coull; Robert O Wright; Andrea Baccarelli; Valentina Bollati; Rosalind J Wright Journal: Environ Res Date: 2020-05-21 Impact factor: 6.498
Authors: Cindy T McEvoy; Lyndsey E Shorey-Kendrick; Kristin Milner; Diane Schilling; Christina Tiller; Brittany Vuylsteke; Ashley Scherman; Keith Jackson; David M Haas; Julia Harris; Byung S Park; Annette Vu; Dale F Kraemer; David Gonzales; Carol Bunten; Eliot R Spindel; Cynthia D Morris; Robert S Tepper Journal: Eur Respir J Date: 2020-07-02 Impact factor: 16.671
Authors: Ashley Scherman; Eliot R Spindel; Byung Park; Robert Tepper; David W Erikson; Cynthia Morris; Cindy T McEvoy Journal: Int J Environ Res Public Health Date: 2021-03-09 Impact factor: 3.390